12:00 AM
Mar 08, 1999
 |  BC Week In Review  |  Clinical News  |  Regulatory

Ortho-McNeil regulatory update

Ortho-McNeil received approval to market Regranex becaplermin platelet-derived growth factor (PDGF)...

Read the full 45 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >